Prevalence of Musculoskeletal Complaints in Nursing Home Residents (NCT06235710) | Clinical Trial Compass
CompletedNot Applicable
Prevalence of Musculoskeletal Complaints in Nursing Home Residents
Netherlands100 participantsStarted 2024-01-18
Plain-language summary
The goal of this observational study is to investigate the prevalence of joint complaints in nursing home residents with and without dementia.
Primary objective: Number of tender or swollen joints.
Secondary objectives:
1. Only when it is possible for the nursing home resident to provide us this information: how nursing home residents themselves assess the severity of their joint complaints that day (at that time). If the nursing home resident cannot answer this question (reliably), the investigators use the Pain Assessment Checklist for Seniors with Severe Dementia (PACSLAC-D).
2. Investigate mobility limitations among nursing home residents.
3. To understand whether an accurate (differential) diagnosis for the joint complaints is reported in the electronic files.
During the study, a standard physical examination of the musculoskeletal system will performed. Nursing home residents allocated in group 1 (no dementia) also provide an answer on 3 non-incriminating questions (severity of joint complaints, pain in general and general health).
Nursing home residents allocated in group 2 (dementia) answer, if possible, 1 non-incriminating question (pain in joints at that moment). These question(s) and the physical examination are also widely used in daily clinical practice. No further incriminating questions or questionnaires will be administered. If the nursing home resident cannot answer this question (reliably), the investigators use the PACSLAC-D.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria, group 1:
* Mentally competent nursing home resident ≥ 65 years;
* No diagnosis of dementia (major neurocognitive disorder according to DSM-5 criteria);
* The nursing home resident provides informed consent to participate in the study.
Inclusion criteria, group 2:
* Nursing home resident with dementia (major neurocognitive disorder according to DSM-5 criteria) ≥ 65 years;
* The legal representative of the nursing home resident provides informed consent to participate in the study.
Exclusion criteria, group 1:
* Diagnosis dementia;
* Life expectancy \< 2 weeks (definition terminal nursing home resident). Exclusion criteria, group 2
* Life expectancy \< 2 weeks (definition terminal nursing home resident).
* If, on the basis of an already known pattern of behaviour, it is expected that the potential participant will resist the proposed research (anticipated behaviour).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The prevalence of joint complaints in nursing home residents with and without dementia.